Your browser doesn't support javascript.
loading
Correction: Ponzo et al. Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression. Cancers 2022, 14, 4265.
Ponzo, Matteo; Debesset, Anais; Cossutta, Mélissande; Chalabi-Dchar, Mounira; Houppe, Claire; Pilon, Caroline; Nicolas-Boluda, Alba; Meunier, Sylvain; Raineri, Fabio; Thiolat, Allan; Nicolle, Rémy; Maione, Federica; Brundu, Serena; Cojocaru, Carina Florina; Bouvet, Philippe; Bousquet, Corinne; Gazeau, Florence; Tournigand, Christophe; Courty, José; Giraudo, Enrico; Cohen, José L; Cascone, Ilaria.
Afiliação
  • Ponzo M; Immune Regulation and Biotherapy, Inserm U955, IMRB University of Paris-Est Creteil (UPEC) 8, INSERM, IMRB, F-94010 Créteil, France.
  • Debesset A; Immune Regulation and Biotherapy, Inserm U955, IMRB University of Paris-Est Creteil (UPEC) 8, INSERM, IMRB, F-94010 Créteil, France.
  • Cossutta M; Immune Regulation and Biotherapy, Inserm U955, IMRB University of Paris-Est Creteil (UPEC) 8, INSERM, IMRB, F-94010 Créteil, France.
  • Chalabi-Dchar M; Cancer Research Center of Lyon, Cancer Cell Plasticity Department, University of Lyon, UMR INSERM 1052 CNRS 5286, Centre Léon Bérard, F-69008 Lyon, France.
  • Houppe C; Immune Regulation and Biotherapy, Inserm U955, IMRB University of Paris-Est Creteil (UPEC) 8, INSERM, IMRB, F-94010 Créteil, France.
  • Pilon C; Immune Regulation and Biotherapy, Inserm U955, IMRB University of Paris-Est Creteil (UPEC) 8, INSERM, IMRB, F-94010 Créteil, France.
  • Nicolas-Boluda A; AP-HP, Groupe Hospitalo-Universitaire Chenevier Mondor, Centre D'investigation Clinique Biothérapie, F-94010 Créteil, France.
  • Meunier S; Matières et Systèmes Complexes (MSC), Université de Paris, CNRS UMR 7057, F-75006 Paris, France.
  • Raineri F; Immune Regulation and Biotherapy, Inserm U955, IMRB University of Paris-Est Creteil (UPEC) 8, INSERM, IMRB, F-94010 Créteil, France.
  • Thiolat A; Immune Regulation and Biotherapy, Inserm U955, IMRB University of Paris-Est Creteil (UPEC) 8, INSERM, IMRB, F-94010 Créteil, France.
  • Nicolle R; Immune Regulation and Biotherapy, Inserm U955, IMRB University of Paris-Est Creteil (UPEC) 8, INSERM, IMRB, F-94010 Créteil, France.
  • Maione F; Programme Cartes d'Identité des Tumeurs (CIT), Ligue Nationale Contre le Cancer, F-75013 Paris, France.
  • Brundu S; Laboratory of Tumor Microenvironment, Candiolo Cancer Institute, FPO-IRCCS, 10060 Candiolo, Italy.
  • Cojocaru CF; Department of Science and Drug Technology, University of Torino, 10125 Torino, Italy.
  • Bouvet P; Laboratory of Tumor Microenvironment, Candiolo Cancer Institute, FPO-IRCCS, 10060 Candiolo, Italy.
  • Bousquet C; Department of Science and Drug Technology, University of Torino, 10125 Torino, Italy.
  • Gazeau F; Laboratory of Tumor Microenvironment, Candiolo Cancer Institute, FPO-IRCCS, 10060 Candiolo, Italy.
  • Tournigand C; Department of Science and Drug Technology, University of Torino, 10125 Torino, Italy.
  • Courty J; Matières et Systèmes Complexes (MSC), Université de Paris, CNRS UMR 7057, F-75006 Paris, France.
  • Giraudo E; Ecole Normale Supérieure de Lyon, University of Lyon, F-69342 Lyon, France.
  • Cohen JL; UMR INSERM-1037, Cancer Research Center of Toulouse (CRCT), Toulouse University III, F-31037 Toulouse, France.
  • Cascone I; AP-HP, Groupe Hospitalo-Universitaire Chenevier Mondor, Centre D'investigation Clinique Biothérapie, F-94010 Créteil, France.
Cancers (Basel) ; 14(24)2022 Dec 14.
Article em En | MEDLINE | ID: mdl-36551754
ABSTRACT
In the original publication [...].
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França